Our own unpublished studies indicate that up-regulation of ABCA1 is observed in CML patients that develop resistance to IM (data not shown), suggesting that alterations of ABC transporters mediated by miRNAs might be a mechanism of resistance to IM. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.